Home › Focal Segmental Glomerulosclerosis › Ohio
Pag-aaral pangklinika para sa Focal Segmental Glomerulosclerosis sa Ohio
8 pag-aaral para sa Focal Segmental Glomerulosclerosis ang naghahanap ng mga kalahok sa mga site sa Ohio.
Mga Lungsod sa Ohio
Opisyal na teksto ng pag-aaral (English)
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- Cleveland Clinic - Cleveland- Site Number : 8400029, Cleveland
Nagre-recruitPhase 2
Edad 16 hanggang 75 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT06500702A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
- Americare Kidney Institute - Brunswick, Brunswick
- The Kidney and Hypertension Center, Cincinnati
- Cincinnati Children's Hospital Medical Center, Cincinnati
- at 2 pa
Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07220083Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- Akron Children's Hospital, Akron
Nagre-recruit
Hanggang edad 21 · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT02235857Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System
- Akron Children's Hospital, Akron
Nagre-recruit
Hanggang edad 75 · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT04065438A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
- Investigator Site #20, Cleveland
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 13, 2026 · NCT07268638NEPTUNE Match Study
- Cleveland Clinic Foundation, Cleveland
Nagre-recruit
Edad 1 hanggang 80 · Lahat ng kasarian · Na-update Hun 10, 2026 · NCT04571658Nephrotic Syndrome Study Network
- Cleveland Clinic, Cleveland
- The Ohio State University Wexner Medical Center, Columbus
Nagre-recruitObservasyonal na pag-aaral
Hanggang edad 80 · Lahat ng kasarian · Na-update Hun 10, 2026 · NCT01209000Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- Nationwide Children's Hospital, Columbus
Nagre-recruitPhase 2
Edad 1 hanggang 17 · Lahat ng kasarian · Na-update May 12, 2026 · NCT05003986Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.